Catalyst Wire Dossier Catalyst Wire Dossier

Olazax Disperzi

olanzapine · Glenmark Pharmaceuticals s.r.o.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Olazax Disperzi, covering 2020-06-16 to 2020-06-16. Get the full timeline:

Most recent: EMA Authorised: Olazax Disperzi (olanzapine) — Glenmark Pharmaceuticals s.r.o.

See pricing